Data Characteristics in This Category
Pharmacoeconomics data often originates from clinical trial reports, real-world evidence (RWE) studies, health insurance payment standards, drug pricing databases, and reports published by Health Technology Assessment (HTA) agencies. Data update frequency is typically low, usually occurring with new drug launches, adjustments to health insurance catalogs, or the publication of major study results, which may be quarterly, semi-annually, or annually. Document structures commonly include detailed methodology descriptions, cost-utility analysis (CUA), cost-effectiveness analysis (CEA), or cost-benefit analysis (CBA) models, and sensitivity analysis results. Common fields include ICER (Incremental Cost-Effectiveness Ratio), QALY (Quality-Adjusted Life Year), LYG (Life Year Gained), DrugCost (Drug Cost), and MedicalServiceCost (Medical Service Cost). Units involve currencies (e.g., USD, CNY), life years (years), or unitless ratios.
Constraints Imposed by These Characteristics on "Forms and Interactions"
The low update frequency of pharmacoeconomics data means that importing large volumes of historical data at once is a common practice when building a knowledge base, with subsequent updates primarily incremental. Complex document structures require form design to guide users in accurately extracting key metrics, for example, by restricting analysis type choices via dropdown menus. The specificity of fields like ICER and QALY necessitates providing clear field explanations or preset validation rules at the interaction level to prevent user input errors or conceptual confusion. The presence of currency and life-year units requires unit conversion or clear unit labeling before form submission to ensure accurate model comprehension. Furthermore, since data often appears as a mix of structured tables and unstructured text, form and interaction design needs to accommodate both, for example, by supporting PDF report uploads alongside structured data entry.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale for this Value |
|---|---|---|
maxContext | 8192 tokens | Pharmacoeconomics reports contain extensive text, requiring support for a longer context window. |
similarityThreshold | 0.75 | Ensures retrieval of document segments highly relevant to specific economic indicators or analysis methods. |
maxRetrieveResults | 10 entries | Complex queries may involve multi-dimensional data, requiring more retrieval results for comprehensive judgment. |
PARSER_MODE | TABLE_AND_TEXT | Data often includes a large amount of mixed table and text content, requiring balanced parsing. |
documentExpirationTime | 365 days | Considering the low data update frequency, a one-year expiration period can cover most update cycles. |
feedbackThreshold | 0.8 | Ensures the effectiveness of user feedback, filtering out low-confidence feedback. |
Three Common Pitfalls
- The model frequently provides outdated data or cost values with incorrect units when answering questions related to drug costs. This occurs because knowledge base documents are not updated promptly, or currency units are not correctly identified and converted during parsing.
- After a user submits a complex question involving "cost-effectiveness ratio," the model fails to effectively utilize relevant tools for calculation or citation. This happens because tool invocation conditions in the workflow design are too broad, preventing the model from accurately determining when to call specific economic analysis tools.
- After uploading a pharmacoeconomics report PDF, some table data is not correctly extracted, leading to missing key values in subsequent Q&A. This is due to
PARSER_MODEsettings not adequately considering table parsing capabilities, orPARSE_FILE_TIMEOUT_SECONDSbeing too short, causing parsing interruptions.
How to Verify Configuration
- Upload a typical pharmacoeconomics report PDF containing key indicators such as
ICERandQALY, and check if these values and their corresponding units are correctly extracted in the knowledge base. - Simulate user questions such as "What is the incremental cost-effectiveness ratio of drug X?" or "How cost-effective is this drug compared to existing therapies?" Check if the model's answers accurately cite data from the knowledge base and provide reasonable analysis.
- In a workflow configured with external calculation tools (e.g., for
ICERsensitivity analysis), test by inputting a set of parameters to verify if the model triggers tool invocation and returns calculation results.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.